EUVIMEDSkopri EUVIMED
Leserbrief

Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance

Jiajing Zhao, Liping Liu

Alimentary Pharmacology & Therapeutics · 2026-05 · 63 (10) · 1441-1442

DOI: 10.1111/apt.70618 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-03-18. Written by Jiajing Zhao and 1 co-authors. Institution: Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen, China. Cited 1 times so far (Crossref); 10 references.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Ebda abstract disponibbli.

Subjects

Author keywords

antiviral agentsgenetic risk scorehepatitis Chepatocellular carcinoma

Authors and institutions

  • Department of Hepatobiliary and Pancreas Surgery, Shenzhen People's Hospital, the Second Clinical Medical College, Jinan University, Shenzhen, China.
  • Department of Hepatobiliary and Pancreas Surgery, The First Affiliated Hospital (Shenzhen People's Hospital), School of Medicine, Southern University of Science and Technology, Shenzhen, China.

Cite

APA

Zhao, J., & Liu, L. (2026). Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance. Alimentary Pharmacology & Therapeutics, 63(10), 1441-1442. https://doi.org/10.1111/apt.70618

Vancouver

Zhao J, Liu L. Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance. Alimentary Pharmacology & Therapeutics. 2026;63(10):1441-1442. doi:10.1111/apt.70618

BibTeX
@article{Zhao2026,
  author = {Zhao, Jiajing and Liu, Liping},
  title = {Letter: Beyond Association—Operationalising PRS ‐5 for Hepatocellular Carcinoma Surveillance},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {10},
  pages = {1441--1442},
  doi = {10.1111/apt.70618}
}
Start for free →